FIQDX
Price
$9.32
Change
-$0.03 (-0.32%)
Updated
Jun 24 closing price
Net Assets
592.19M
HBLCX
Price
$14.65
Change
+$0.02 (+0.14%)
Updated
Jun 24 closing price
Net Assets
11.15B
Interact to see
Advertisement

FIQDX vs HBLCX

FIQDX vs HBLCX Comparison Chart in %
View a ticker or compare two or three
VS
FIQDX vs. HBLCX commentary
Jun 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIQDX is a Hold and HBLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HBLCX has more cash in the bank: 11.1B vs. FIQDX (592M). FIQDX pays higher dividends than HBLCX: FIQDX (4.20) vs HBLCX (2.49). FIQDX was incepted earlier than HBLCX: FIQDX (8 years) vs HBLCX (20 years). HBLCX (1.65) is less costly to investors than FIQDX (0.68). HBLCX is a more actively managed with annual turnover of: 90.00 vs. FIQDX (29.00). FIQDX has a lower initial minimum investment than HBLCX: FIQDX (0) vs HBLCX (2000). FIQDX annual gain was more profitable for investors over the last year : 12.71 vs. HBLCX (4.11). FIQDX return over 5 years is better than : 33.24 vs. HBLCX (1.89).
FIQDXHBLCXFIQDX / HBLCX
Total Expense Ratio0.611.6537%
Annual Report Gross Expense Ratio0.681.6541%
Fund Existence8 years20 years-
Gain YTD6.2223.319187%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/A2000-
Net Assets592M11.1B5%
Annual Yield % from dividends4.202.49169%
Returns for 1 year12.714.11309%
Returns for 3 years30.3017.42174%
Returns for 5 years33.241.891,760%
Returns for 10 yearsN/A32.68-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNTI1.090.16
+17.36%
Senti Biosciences Holdings Inc.
FCCO32.720.52
+1.61%
First Community Corp
ACI14.130.22
+1.58%
Albertsons Companies
DELL434.066.28
+1.47%
Dell Technologies
MAZE26.670.26
+0.98%
Maze Therapeutics Inc